What additional factors beyond state-of-the-art analytical methods are needed for optimal generation and interpretation of biomonitoring data?

Environmental Health Perspectives

Volumn 117, Issue 10, 2009, Pages 1481-1485

  Calafat, Antonia M ^a   Needham, Larry L ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

BPA; Contamination; DEHP; Extraction efficiency; Field blank; Phthalates

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENVIRONMENTAL CHEMICAL; PHTHALIC ACID; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; POLYBROMINATED DIPHENYL ETHER; POLYVINYLCHLORIDE; VOLATILE ORGANIC COMPOUND;

ANALYTIC METHOD; BIOLOGICAL MONITORING; BODY BURDEN; DATA ANALYSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; GOOD LABORATORY PRACTICE; INFORMATION PROCESSING; MATERIALS HANDLING; NOTE; PRIORITY JOURNAL; QUALITY CONTROL;

BIOLOGICAL MARKERS; BORON COMPOUNDS; DIETHYLHEXYL PHTHALATE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; HUMANS; PHENYLALANINE;

EID: 70449572798     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0901108     Document Type: Note

References (44)

1. Angerer J, Ewers U, Wilhelm M. 2007. Human biomonitoring: state of the art. Int J Hyg Environ Health 210:201-228.
2. Ashley DL, Bonin MA, Cardinali FL, McCraw JM, Holler JS, Needham LL, et al. 1992. Determining volatile organic compounds in human blood from a large sample population by using purge and trap gas chromatography/mass spectrometry. Anal Chem 64:1021-1029.
3. Barr DB, Silva MJ, Kato K, Reidy JA, Malek NA, Hurtz D, et al. 2003. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Environ Health Perspect 111:1148-1151. (Pubitemid 36939393)
4. Barregard L, Sallsten G, Jarvholm B. 1995. People with high mercury uptake from their own dental amalgam fillings. Occup Environ Med 52:124-128.
5. Bolann BJ, Rahil-Khazen R, Henriksen H, Isrenn R, Ulvik RJ. 2007. Evaluation of methods for trace-element determination with emphasis on their usability in the clinical routine laboratory. Scand J Clin Lab Invest 67:353-366. (Pubitemid 46897616)
6. Calafat AM, Needham LL. 2008. Factors affecting the evaluation of biomonitoring data for human exposure assessment. Int J Androl 31:139-143. (Pubitemid 351341353)
7. Calafat AM, Needham LL, Silva MJ, Lambert G. 2004. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics 113:e429-e434.
8. Calafat AM, Weuve J, Ye XY, Jia LT, Hu H, Ringer S, et al. 2009. Exposure to bisphenol A and other phenols in neonatal intensive care unit premature infants. Environ Health Perspect 117:639-644.
9. Caudill SP, Schleicher RL, Pirkle JL. 2008. Multi-rule quality control for the age-related eye disease study. Stat Med 27:4094-4106.
10. CDC (Centers for Disease Control and Prevention). 2003. National Health and Nutrition Examination Survey. National Center for Health Statistics. Available: http://www.cdc.gov/nchs/nhanes.htm [accessed 11 August 2008].
11. CDC. 2005. Third National Report on Human Exposure to Environmental Chemicals. Atlanta, GA:Centers for Disease Control and Prevention; National Center for Environmental Health; Division of Laboratory Sciences. Available: http:// www.cdc.gov/exposurereport/ [accessed 11 April 2009].
12. David RM, McKee RH, Butala JH, Barter RA, Kayser M. 2001. Esters of aromatic mono-, di-, and tricarboxylic acids, aromatic diacids, and di-, tri-, or polyalcohols. In: Patty's Toxicology, Vol 6 (Bingham E, Cohrssen B, Powell CH, eds). 5th ed. New York:John Wiley and Sons, 635-932.
13. Dirven HAAM, VandenBroek PHH, Jongeneelen FJ. 1993. Determination of 4 metabolites of the plasticizer di(2-ethylhexyl) phthalate in human urine samples. Int Arch Occup Environ Health 64:555-560. (Pubitemid 23218122)
14. FDA. 2001. Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices. Rockville, MD:Center for Devices and Radiological Health, U.S. Food and Drug Administration. Available: http://www.fda.gov/cdrh/ ost/dehp-pvc.pdf [accessed 12 February 2009].
15. Fromme H, Tittlemier SA, Volkel W, Wilhelm M, Twardella D. 2009. Perfluorinated compounds - exposure assessment for the general population in western countries. Int J Hyg Environ Health 212:239-270.
16. Golding J, Pembrey M, Jones R, Alspac Study Team. 2001. ALSPAC - the Avon Longitudinal Study of Parents and Children - I. Study methodology. Paediatr Perinat Epidemiol 15:74-87. (Pubitemid 32155760)
17. Holmes AK, Maisonet M, Rubin C, Kieszak S, Barr DB, Calafat AM, et al. In press. A pilot study of exposures to endocrine-disrupting compounds in pregnant women and children from the United Kingdom. Int J Child Adolesc Health.
18. Hwang HM, Park EK, Young TM, Hammock BD. 2008. Occurrence of endocrine-disrupting chemicals in indoor dust. Sci Total Environ 404:26-35.
19. Kato K, Silva MJ, Reidy JA, Hurtz D, Malek NA, Needham LL, et al. 2004. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ Health Perspect 112:327-330. (Pubitemid 38351395)
20. Kerns EH, Di L, Carter GT. 2008. In vitro solubility assays in drug discovery. Curr Drug Metabol 9:879-885.
21. Koch HM, Angerer J, Drexler H, Eckstein R, Weisbach V. 2005a. Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors. Int J Hyg Environ Health 208:489-498. (Pubitemid 41527207)
22. Koch HM, Bolt HM, Angerer J. 2004. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP. Arch Toxicol 78:123-130. (Pubitemid 38657193)
23. Koch HM, Bolt HM, Preuss R, Angerer J. 2005b. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol 79:367-376. (Pubitemid 41040172)
24. Koch HM, Preuss R, Angerer J. 2006. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure - an update and latest results. Int J Androl 29:155-165.
25. Koch HM, Rossbach B, Drexler H, Angerer J. 2003. Internal exposure of the general population to DEHP and other phthalates - determination of secondary and primary phthalate monoester metabolites in urine. Environ Res 93:177-185. (Pubitemid 37083327)
26. Lee EJ, Arbuckle TE. 2009. Urine sampling methods for environmental chemicals in infants and young children. J Expos Sci Environ Epidemiol; doi:10.1038/jes.2009.36 [Online 24 June 2009].
27. Nakamiya K, Takagi H, Nakayama T, Ito H, Tsuruga H, Edmonds JS, et al. 2005. Microbial production and vaporization of mono-(2-ethylhexyl) phthalate from di-(2-ethylhexyl) phthalate by microorganisms inside houses. Arch Environ Occup Health 60:321-325. (Pubitemid 46595862)
28. National Children's Study. 2009. National Children's Study. Available: http://www.nationalchildrensstudy.gov/ [accessed 23 February 2009].
29. National Research Council. 2006. Human Biomonitoring for Environmental Chemicals. Washington, DC:National Academies Press.
30. National Toxicology Program. 2008. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Bisphenol A. Available: http://cerhr.niehs.nih.gov/chemicals/bisphenol/bisphenol.pdf [accessed 3 September 2008].
31. Needham LL, Calafat AM, Barr DB. 2007. Uses and issues of biomonitoring. Int J Hyg Environ Health 210:229-238.
32. Needham LL, Patterson DG, Barr DB, Grainger J, Calafat AM. 2005. Uses of speciation techniques in biomonitoring for assessing human exposure to organic environmental chemicals. Anal Bioanal Chem 381:397-404. (Pubitemid 40249161)
33. NIOSH (National Institute for Occupational Safety and Health). 1994. NIOSH Manual of Analytical Methods. 4th ed. Available: http://www.cdc.gov/niosh/ nmam/chaps.html [accessed 23 November 2008].
34. Peck CC, Albro PW. 1982. Toxic potential of the plasticizer di(2-ethylhexyl) phthalate in the context of its disposition and metabolism in primates and man. Environ Health Perspect 45:11-17.
35. Pineau A, Guillard O, Chappuis P, Arnaud J, Zawislak R. 1993. Sampling conditions for biological fluids for trace elements monitoring in hospital patients: a critical approach. Crit Rev Clin Lab Sci 30:203-222. (Pubitemid 23287831)
36. Rudel RA, Perovich LJ. 2009. Endocrine disrupting chemicals in indoor and outdoor air. Atmos Environ 43:170-181.
37. Silva MJ, Reidy A, Preau JL, Samandar E, Needham LL, Calafat AM. 2006. Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate as biomarkers for human exposure assessment. Biomarkers 11:1-13. (Pubitemid 43250548)
38. Staples CA, Peterson DR, Parkerton TF, Adams WJ. 1997. The environmental fate of phthalate esters: a literature review. Chemosphere 35:667-749. (Pubitemid 27343167)
39. Taylor JK. 1987. Quality Assurance of Chemical Measurements. Chelsea, MI:Lewis Publishers.
40. Viso A-C, Eilstein D, Medeiros H, eds. 2009. Human biomonitoring and environmental health. In: Bulletin Épidémiologique Hebdomadaire, spec ed. Saint-Maurice, France:Institute de Veille Sanitaire, 1-27.
41. Volkel W, Kiranoglu M, Fromme H. 2008. Determination of free and total bisphenol A in human urine to assess daily uptake as a basis for a valid risk assessment. Toxicol Lett 179:155-162.
42. Weschler CJ. 2009. Changes in indoor pollutants since the 1950s. Atmos Environ 43:153-169.
43. Wilson NK, Chuang JC, Lyu C, Menton R, Morgan MK. 2003. Aggregate exposures of nine preschool children to persistent organic pollutants at day care and at home. J Expos Anal Environ Epidemiol 13:187-202. (Pubitemid 36753834)
44. Yan X, Calafat A, Lashley S, Smulian J, Ananth C, Barr D, et al. 2009. Phthalates biomarker identification and exposure estimates in a population of pregnant women. Hum Ecol Risk Assess 15:565-578.